RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tetra Bio Pharma Stock

Tetra Bio Pharma ROA 2024

Tetra Bio Pharma ROA

-6.91

Ticker

TBPMQ

ISIN

CA88166Y1007

WKN

A2ASQ8

In 2024, Tetra Bio Pharma's return on assets (ROA) was -6.91, a 0% increase from the 0 ROA in the previous year.

Tetra Bio Pharma Aktienanalyse

What does Tetra Bio Pharma do?

Tetra Bio-Pharma Inc. is a Canadian biotechnology company focused on the development and commercialization of new therapeutic products for pain relief and other severe diseases. It was founded in 2007 and has been publicly listed on the Canadian Securities Exchange since 2013. Tetra Bio Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Tetra Bio Pharma's Return on Assets (ROA)

Tetra Bio Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Tetra Bio Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Tetra Bio Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Tetra Bio Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Tetra Bio Pharma stock

What is the Return on Assets (ROA) of Tetra Bio Pharma this year?

The Return on Assets (ROA) of Tetra Bio Pharma is -6.91 undefined this year.

What was the ROA of Tetra Bio Pharma compared to the previous year?

The ROA of Tetra Bio Pharma has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Tetra Bio Pharma?

A high ROA is advantageous for investors of Tetra Bio Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Tetra Bio Pharma?

A low ROA can be unfavorable for investors of Tetra Bio Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Tetra Bio Pharma affect the company?

An increase in ROA of Tetra Bio Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Tetra Bio Pharma impact the company?

A reduction in the ROA of Tetra Bio Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Tetra Bio Pharma?

Some factors that can influence the ROA of Tetra Bio Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Tetra Bio Pharma important for investors?

The ROA of Tetra Bio Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Tetra Bio Pharma take to improve ROA?

To improve ROA, Tetra Bio Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Tetra Bio Pharma pay?

Over the past 12 months, Tetra Bio Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tetra Bio Pharma is expected to pay a dividend of 0 CAD.

What is the dividend yield of Tetra Bio Pharma?

The current dividend yield of Tetra Bio Pharma is .

When does Tetra Bio Pharma pay dividends?

Tetra Bio Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tetra Bio Pharma?

Tetra Bio Pharma paid dividends every year for the past 0 years.

What is the dividend of Tetra Bio Pharma?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tetra Bio Pharma located?

Tetra Bio Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tetra Bio Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tetra Bio Pharma from 11/20/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Tetra Bio Pharma pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Tetra Bio Pharma in the year 2023?

In the year 2023, Tetra Bio Pharma distributed 0 CAD as dividends.

In which currency does Tetra Bio Pharma pay out the dividend?

The dividends of Tetra Bio Pharma are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Tetra Bio Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Tetra Bio Pharma

Our stock analysis for Tetra Bio Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tetra Bio Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.